Bioidentical Hormone Therapy

Bioidentical hormones have the same molecular structure as those the human body makes: estradiol, progesterone and testosterone. The term describes chemistry, not source or regulation. Many bioidentical products are made in a laboratory from plant precursors such as yam or soy, and several are FDA-approved, standardised medicines. Estradiol patches, estradiol gels and micronised progesterone capsules are all bioidentical in this sense.

The confusion comes from "bioidentical" also being used as a marketing label for custom-compounded preparations, sometimes implying they are safer or more natural than conventional therapy. The chemistry of the molecule does not support that claim on its own, and major medical societies do not recommend compounded products over approved ones when an approved equivalent exists.

FDA-approved bioidentical products have been tested for dose accuracy, purity and batch-to-batch consistency, and their labels carry standardised safety warnings. Compounded preparations are made by a pharmacy for an individual prescription. They can be appropriate when a patient needs a strength, base or combination no approved product offers, but the FDA does not review them for safety, effectiveness or quality.

In practice that means two things for you as a patient. First, ask whether your prescription is an approved product or a compounded one. Second, if it is compounded, ask which pharmacy prepares it and whether it is accredited and tests its finished product.

There is good evidence that some bioidentical choices carry a better risk profile than some older options. Transdermal estradiol has a lower clot risk than oral conjugated estrogens, and micronised progesterone appears to carry less cardiovascular and breast-related risk than some synthetic progestins. Those advantages come from the specific molecule and route chosen, not from the word bioidentical itself.

What is missing is high-quality evidence that custom-compounded bioidentical regimens, dosed using saliva tests or similar, are safer or more effective than standard approved therapy. Be cautious of any provider who guarantees superior results, leans heavily on salivary hormone panels to set doses, or discourages you from discussing risks.

A sensible protocol starts with your symptoms, medical history and whether you have a uterus, then picks a standard starting dose and adjusts it by how you feel. Blood tests can confirm that levels are in a reasonable range and are most useful when a symptom is not responding or a transdermal dose needs checking, but treating a number rather than the person is not good practice.

Expect a follow-up around six to twelve weeks, a dose review if symptoms persist or side effects appear, and a yearly review after that. Combination products holding both estradiol and progesterone in one preparation simplify the routine but make it harder to adjust one hormone independently, a real trade-off worth discussing.

Most women who choose this route want hormones that match their own physiology, prefer transdermal delivery, or have found oral synthetic products hard to tolerate. Women who need unusual strengths, have excipient allergies or want a combined product may be offered a compounded option. Telehealth providers focused on bioidentical therapy are compared in our menopause rankings and in our reviews of Winona and others.